One in four patients say they’ve skimped on insulin because of high cost, and over a third of those patients experiencing cost-related underuse said they never discussed this reality with their provider, finds a new study.

One in four patients say they’ve skimped on insulin because of high cost, and over a third of those patients experiencing cost-related underuse said they never discussed this reality with their provider, finds a new study.: https://ift.tt/2AJg9Cm Read more... https://ift.tt/2PjQq8K